Financials

  • Market Capitalization 8.27 M
  • Employee 14
  • Founded 1987
  • CEO N/A
  • Website www.soligenix.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVMHG5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.53
Relación precio/flujo de caja
139.6

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4793
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.89 USD+1.90%+1.55%+2.43%-3.92%8.61 M USD
4797
XCUR
Exicure, Inc. - Common Stock
1.30 USD-0.76%+9.24%-14.47%-75.70%8.51 M USD
4812
SKYE
Skye Bioscience, Inc. - Common Stock
1.80 USD+7.14%-10.89%+215.79%+125.00%7.97 M USD
4817
ALZN
Alzamend Neuro, Inc. - Common Stock
1.64 USD+2.50%+3.14%+27.13%-30.21%7.86 M USD

Noticias